Website profile

Pharmadispatch

News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals

  • 220articles · 365d
  • 6+ hour agolatest article
  • Jan 21, 2026earliest in window
  • 90%with images
  • 159avg words
articles per day
Categories
  • Medical 203
  • Health 153
  • Health & Wellness 146
  • Business & Industrial 72
  • Economy, Business & Finance 33
  • Science & Technology 23
  • Finance & Business 13
  • Education 3

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

PharmaDispatch
pharmadispatch.com > news > canberra-details-tax-changes-with-limited-concessions-for-some-innovators

Canberra details tax changes with limited concessions for some innovators

6+ hour, 27+ min ago   (100+ words) PharmaDispatch Canberra details tax changes with limited concessions for some innovators AusBiotech has welcomed concessions to changes to the R&D Tax Incentive and Capital Gains Tax but remains concerned about the potential impact on emerging life sciences companies. … Rare…...

PharmaDispatch
pharmadispatch.com > news > guilt-over-this-enduring-failure-is-the-correct-response

Guilt over this enduring failure is the correct response

4+ day, 18+ hour ago   (157+ words) PharmaDispatch Guilt over this enduring failure is the correct response We live in a wealthy country where this situation has been allowed to persist. Responsibility is not shared equally. Those with the authority to design, operate and change the system…...

PharmaDispatch
pharmadispatch.com > news > bupa-to-discontinue-international-referrals-for-doctors-on-demand-telehealth

Bupa to discontinue international referrals for 'Doctors on Demand' telehealth

6+ day, 12+ hour ago   (139+ words) PharmaDispatch Bupa to discontinue international referrals for 'Doctors on Demand' telehealth Vitura Health has updated investors, confirming that Bupa will discontinue its international patient referrals from the Doctors on Demand telehealth business. … Five years, 1,826 days, and we are still going…...

PharmaDispatch
pharmadispatch.com > news > five-years-1826-days-and-we-are-still-going-on-the-hta-review

Five years, 1,826 days, and we are still going on the HTA Review

1+ week, 29+ min ago   (114+ words) PharmaDispatch Five years, 1,826 days, and we are still going on the HTA Review Today marks the fifth anniversary of former health minister Greg Hunt's announcement that Australia would conduct a review of health technology assessment. … The 'Dispatched' Week in Review…...

PharmaDispatch
pharmadispatch.com > news > an-institution-dominated-by-very-clever-people-but-where-is-the-wisdom

An institution dominated by very clever people, but where is the wisdom?

1+ mon, 4+ hour ago   (171+ words) PharmaDispatch An institution dominated by very clever people, but where is the wisdom? An enduring saying is that intelligence is knowing a tomato is a fruit, while wisdom is knowing not to put it in a fruit salad. Everyone knows…...

PharmaDispatch
pharmadispatch.com > news > vvmf-and-optosleep-partner-to-advance-australian-gene-therapy-for-sleep-apnoea

VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea

1+ mon, 13+ hour ago   (134+ words) PharmaDispatch VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea Australia’s viral vector manufacturing capability is set to support the development of a novel gene therapy and light-based treatment approach for obstructive sleep apnoea under a new…...

PharmaDispatch
pharmadispatch.com > news > how-education-reveals-the-terrible-moral-and-ethical-limits-of-our-health-decision-making

How education exposes the moral and ethical limits of our health decision-making

1+ mon, 3+ day ago   (143+ words) PharmaDispatch How education exposes the moral and ethical limits of our health decision-making The clearest way to see what is troubling about our use of health-technology assessment is to apply its logic to another social program, such as education. How…...

PharmaDispatch
pharmadispatch.com > news > the-risk-to-patients-is-that-new-pricing-policies-could-swamp-any-benefit-from-the-hta-review

The risk to patients is that new pricing policies could swamp any benefit from the HTA Review

1+ mon, 1+ week ago   (129+ words) PharmaDispatch The risk to patients is that new pricing policies could swamp any benefit from the HTA Review The pricing outcomes negotiated in these agreements will likely have a far bigger impact on access outcomes than anything implemented as a…...

PharmaDispatch
pharmadispatch.com > news > long-covid-still-reshaping-life-for-medically-vulnerable-australians

Long-COVID still reshaping life for medically vulnerable Australians

1+ mon, 2+ week ago   (125+ words) PharmaDispatch Long-COVID still reshaping life for medically vulnerable Australians A new global survey, including Australia, has painted a stark picture of how COVID-19 continues to shape daily life for many medically vulnerable people. … New AI platform aims to give patients…...

PharmaDispatch
pharmadispatch.com > news > ew-research-shows-chronic-pain-is-widespread-and-undertreated-in-australia

New research shows chronic pain is widespread and undertreated in Australia

1+ mon, 2+ week ago   (139+ words) PharmaDispatch New research shows chronic pain is widespread and undertreated in Australia Chronic Pain Australia’s '2026 National Pain Report: Pain Lives Here', released during National Pain Week, is calling for action on the disconnect between the widespread impact of chronic pain…...